TY - JOUR T1 - Experimental bluetongue virus superinfection in calves previously immunized with bluetongue virus serotype 8. JF - Vet Res Y1 - 2016 A1 - Martinelle, Ludovic A1 - Dal Pozzo, Fabiana A1 - Sarradin, Pierre A1 - Willem Van Campe A1 - Ilse De Leeuw A1 - Kris De Clercq A1 - Thys, Christine A1 - Thiry, Etienne A1 - Saegerman, Claude KW - Animals KW - Bluetongue KW - Bluetongue virus KW - Cattle KW - Cattle Diseases KW - Female KW - Male KW - Superinfection KW - Viral Vaccines AB -

The effect of a superinfection with bluetongue virus serotype 1 (BTV1) was evaluated on two groups of four calves. One group received a commercial inactivated BTV serotype 8 (BTV8) vaccine. This group and the non-vaccinated group of calves were challenged twice (4 months apart) with the European BTV8 strain isolated during the 2006-2007 epidemics. Calves were then infected with a BTV1 inoculum which was found to be unexpectedly contaminated by BTV serotype 15 (BTV15). BTV1 and BTV15 single infections were performed on two other groups of three BTV naïve calves. A severe clinical picture was obtained after superinfection with BTV1/BTV15 in both vaccinated and non-vaccinated animals and after challenge with BTV8 in non-vaccinated animals. BTV1 and BTV15 single infection caused only very slight clinical signs. After superinfection and at the viraemic peak, there were an average of above 1000 times more BTV15 genomic copies than BTV1 ones. BTV1 RNA could be detected only in the spleen of one calf whereas BTV15 RNA was found in 15 organs of seven different animals. BTV8 immunization whether it was acquired through vaccination and challenges or challenges alone did not change BTV1 or BTV15 RNA detection in superinfected animals. However in these animals a partial cross neutralization between BTV8 and BTV1 might be involved in the lower BTV1 replication versus BTV15. Infection with different serotypes can occur also in the field. Interference between virus strains, genetic reassortment and cross-protection were considered as mechanisms to explain the clinical outcomes and the other virological and immunological findings in the course of BTV1/BTV15 superinfection.

VL - 47 CP - 1 U1 - https://www.ncbi.nlm.nih.gov/pubmed/27465686?dopt=Abstract M3 - 10.1186/s13567-016-0357-6 ER -